Cool Gear introduces on-the-go travel containers
PLYMOUTH, Mass. — Cool Gear has introduced new liquid travel containers that are ideal for air travel.
Go Gear travel tubes are made of squeezable BPA-free silicone material and feature easy-to-fill wide-mouth bottle openings for simple liquid transferring and dispensing, Cool Gear said. Go Gear products are available in 1.25-oz., 2-oz. and 3-oz. sizes, meeting airline-approved guidelines for the size of carry-on liquids. Additionally, Go Gear products come with write-on sticker labels to help users identify contents, and are available in turquoise, green and magenta.
Go Gear now is available nationwide at Walmart and also will be available at CVS/pharmacy. Prices range from $2.97 for individual tubes to $8 to $10 for assorted 3-packs.
No comments found
Shoppers Drug Mart appoints Domenic Pilla as president, CEO
TORONTO — Shoppers Drug Mart has named Domenic Pilla as its president and CEO, the company said.
Pilla, most recently president of McKesson Canada, will take the new position at the 1,190-store Canadian chain starting Nov. 1. Pilla has worked in retailing and health care for nearly 30 years, including experience in retail pharmacy, pharmaceutical distribution and sales management, specialty health networks, chronic disease management and adherence and health information technology.
"I am delighted to join Shoppers Drug Mart at this time of challenge and reform in healthcare and community pharmacy," Pilla said. "A time of change is also a window of opportunity for the company to continue to lead the industry in providing innovative patient services, while driving organizational efficiencies and continued growth in the retail sector."
Domenic Pilla has the strength and range of leadership, the collaborative ability, combined with a deep passion and caring for the pharmaceutical care industry in Canada. Whether it is their associate group, their governance group or their investor relations, I believe he can effectively and sensitively engage all levels of interest in a comprehensible dialogue which creates happier WIN-WIN outcomes for all levels of the organization.
Sun Pharma resolves FDA warning letter
MUMBAI, India — Sun Pharmaceutical Industries last month said that it has resolved issues cited in a warning letter sent to the company by the Food and Drug Administration pertaining to one of Sun Pharma’s U.S.-based manufacturing facilities.
The generic drug maker said its wholly owned subsidiary received the go-ahead from the FDA following a reinspection of the plant, located in Cranbury, N.J., which was conducted this past June. The warning letter, which was issued Aug. 25, 2010, was considered resolved after the plant was declared as having acceptable regulatory status.
No comments found